<code id='242431A40F'></code><style id='242431A40F'></style>
    • <acronym id='242431A40F'></acronym>
      <center id='242431A40F'><center id='242431A40F'><tfoot id='242431A40F'></tfoot></center><abbr id='242431A40F'><dir id='242431A40F'><tfoot id='242431A40F'></tfoot><noframes id='242431A40F'>

    • <optgroup id='242431A40F'><strike id='242431A40F'><sup id='242431A40F'></sup></strike><code id='242431A40F'></code></optgroup>
        1. <b id='242431A40F'><label id='242431A40F'><select id='242431A40F'><dt id='242431A40F'><span id='242431A40F'></span></dt></select></label></b><u id='242431A40F'></u>
          <i id='242431A40F'><strike id='242431A40F'><tt id='242431A40F'><pre id='242431A40F'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:hotspot    Page View:7993

          Here at STAT, we spend a lot of time trying to imagine — and render — the invisible. We’ve gone inside of a developing embryo. We’ve flown inside our mouths to show the bacterial tribes that take root there. We’ve traveled through time and space to bring back to life a hallowed surgical theater. We’ve followed sound waves through our inner ears into our brains.

          Of all of these fantastic journeys, one of the hardest subjects to capture, visually, has been CRISPR. Others have tried to capture the essence of the powerful gene-editing technique with the use of analogies.

          advertisement

          Above, you can find our latest visual attempt to wrangle the genetic complexities of CRISPR into lively, and hopefully enjoyable, two minutes.

          explore

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          CDC picks Alphabet's Verily for wasterwater surveillance contract
          CDC picks Alphabet's Verily for wasterwater surveillance contract

          AdobeAlphabet’slifesciencescompanyVerilyhasscoreditsfirstCentersforDiseaseControlandPreventioncontra

          read more
          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more

          FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

          MarkJ.Terrill/APAfollow-upstudyofafirst-of-its-kindcancertreatmentmayreflectsystemicbiases,theFoodan